Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum coding and non‐coding RNAs as biomarkers of NAFLD and fibrosis severity

6 Jun 2019

Abstract excerpt

BACKGROUND & AIMS: In patients with non-alcoholic fatty liver disease (NAFLD), liver biopsy is the gold standard to detect non-alcoholic steatohepatitis (NASH) and stage liver fibrosis. We aimed to identify differentially expressed mRNAs and non-coding RNAs in serum samples of biopsy-diagnosed mild and severe NAFLD patients with respect to controls and to each other. METHODS: We first performed a whole...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatitis B Virus Studies
Share to Hepatitis C virus research
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31169972
DOI: 10.1111/liv.14167

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum coding and non‐coding RNAs as biomarkers of NAFLD and fibrosis severityPMID 31169972Read ↗

Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes.Semantic proximity Read ↗

Systematic Analysis of Long Non-Coding RNA Genes in Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

A proteo-transcriptomic map of non-alcoholic fatty liver disease signaturesSemantic proximity Read ↗

Comprehensive analysis of endoplasmic reticulum-related and secretome gene expression profiles in the progression of non-alcoholic fatty liver diseaseSemantic proximity Read ↗

A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severitySemantic proximity Read ↗

Bioinformatics analysis of ferroptosis-related genes and immune cell infiltration in non-alcoholic fatty liver diseaseSemantic proximity Read ↗

Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severitySemantic proximity Read ↗

Unveiling the pathogenesis of non-alcoholic fatty liver disease by decoding biomarkers through integrated single-cell and single-nucleus profilesSemantic proximity Read ↗

Transcriptomic Profiling of Obesity-Related Nonalcoholic Steatohepatitis Reveals a Core Set of Fibrosis-Specific GenesSemantic proximity Read ↗

MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Bioinformatic analysis of ferroptosis-related genes and immune cell infiltration in non-alcoholic fatty liver diseaseSemantic proximity Read ↗

Comprehensive analysis of epigenetic and epitranscriptomic genes’ expression in human NAFLDSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.